These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30874605)

  • 1. Antibody-mediated clearance of tau in primary mouse microglial cultures requires Fcγ-receptor binding and functional lysosomes.
    Andersson CR; Falsig J; Stavenhagen JB; Christensen S; Kartberg F; Rosenqvist N; Finsen B; Pedersen JT
    Sci Rep; 2019 Mar; 9(1):4658. PubMed ID: 30874605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement.
    Lee SH; Le Pichon CE; Adolfsson O; Gafner V; Pihlgren M; Lin H; Solanoy H; Brendza R; Ngu H; Foreman O; Chan R; Ernst JA; DiCara D; Hotzel I; Srinivasan K; Hansen DV; Atwal J; Lu Y; Bumbaca D; Pfeifer A; Watts RJ; Muhs A; Scearce-Levie K; Ayalon G
    Cell Rep; 2016 Aug; 16(6):1690-1700. PubMed ID: 27475227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Therapeutic Mechanisms of Tau Antibodies: Promoting Microglial Clearance Versus Blocking Neuronal Uptake.
    Funk KE; Mirbaha H; Jiang H; Holtzman DM; Diamond MI
    J Biol Chem; 2015 Aug; 290(35):21652-62. PubMed ID: 26126828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody uptake into neurons occurs primarily via clathrin-dependent Fcγ receptor endocytosis and is a prerequisite for acute tau protein clearance.
    Congdon EE; Gu J; Sait HB; Sigurdsson EM
    J Biol Chem; 2013 Dec; 288(49):35452-65. PubMed ID: 24163366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody.
    Luo W; Liu W; Hu X; Hanna M; Caravaca A; Paul SM
    Sci Rep; 2015 Jun; 5():11161. PubMed ID: 26057852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia.
    De Marco D; Taggenbrock R; Crespo R; Koudstaal W; Ramsburg E; Apetri A
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30474638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent effects of microglial inhibition in vivo on Alzheimer's disease neuropathology using bioactive-conjugated iron oxide nanoparticles.
    Glat M; Skaat H; Menkes-Caspi N; Margel S; Stern EA
    J Nanobiotechnology; 2013 Sep; 11():32. PubMed ID: 24059692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
    Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
    J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice.
    Bajracharya R; Brici D; Bodea LG; Janowicz PW; Götz J; Nisbet RM
    Acta Neuropathol Commun; 2021 Mar; 9(1):42. PubMed ID: 33712083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of CX3CR1 impairs the internalization of Tau by microglia.
    Bolós M; Llorens-Martín M; Perea JR; Jurado-Arjona J; Rábano A; Hernández F; Avila J
    Mol Neurodegener; 2017 Aug; 12(1):59. PubMed ID: 28810892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
    Wang H; Li Y; Ryder JW; Hole JT; Ebert PJ; Airey DC; Qian HR; Logsdon B; Fisher A; Ahmed Z; Murray TK; Cavallini A; Bose S; Eastwood BJ; Collier DA; Dage JL; Miller BB; Merchant KM; O'Neill MJ; Demattos RB
    Mol Neurodegener; 2018 Dec; 13(1):65. PubMed ID: 30558641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease.
    Collin L; Bohrmann B; Göpfert U; Oroszlan-Szovik K; Ozmen L; Grüninger F
    Brain; 2014 Oct; 137(Pt 10):2834-46. PubMed ID: 25085375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
    Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau protein pathology.
    Gu J; Congdon EE; Sigurdsson EM
    J Biol Chem; 2013 Nov; 288(46):33081-95. PubMed ID: 24089520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L.
    Sasaki A; Kawarabayashi T; Murakami T; Matsubara E; Ikeda M; Hagiwara H; Westaway D; George-Hyslop PS; Shoji M; Nakazato Y
    Brain Res; 2008 Jun; 1214():159-68. PubMed ID: 18457819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.
    Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K
    Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.